English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background  In molecular imaging and nuclear medicine, theranostic agents that integrate radionuclide pairs are successfully being used for individualized care, which has led to rapidly growing interest in their continued development. These compounds, which are radiolabeled with one radionuclide for imaging and a chemically identical or similar radionuclide for therapy, may improve patient-specific treatment and outcomes by matching the properties of different radionuclides with a targeting vector for a particular tumor type. One proposed theranostic radionuclide is scandium-47 ( 47 Sc,  T  1/2  = 3.35 days), which can be used for targeted radiotherapy and may be paired with the positron emitting radionuclides,  43 Sc ( T  1/2  = 3.89 h) and  44 Sc ( T  1/2  = 3.97 h) for imaging. The aim of this study was to investigate the photonuclear production of  47 Sc via the  48 Ti(γ,p) 47 Sc reaction using an electron linear accelerator (eLINAC), separation and purification of  47 Sc, the radiolabeling of somatostatin receptor-targeting peptide DOTATOC with  47 Sc, and in vitro receptor-mediated binding of [ 47 Sc]Sc-DOTATOC in AR42J somatostatin receptor subtype two (SSTR2) expressing rat pancreatic tumor cells.    Results  The rate of  47 Sc production in a stack of natural titanium foils ( n  = 39) was 8 × 10 7  Bq/mA·h ( n  = 3). Irradiated target foils were dissolved in 2.0 M H 2 SO 4  under reflux. After dissolution, trivalent  47 Sc ions were separated from natural Ti using AG MP-50 cation exchange resin. The recovered  47 Sc was then purified using CHELEX 100 ion exchange resin. The average decay-corrected two-step  47 Sc recovery ( n  = 9) was (77 ± 7)%. A radiolabeling yield of > 99.9% of [ 47 Sc]Sc-DOTATOC (0.384 mg in 0.3 mL) was achieved using 1.7 MBq of  47 Sc. Blocking studies using Octreotide illustrated receptor-mediated uptake of [ 47 Sc]Sc-DOTATOC in AR42J cells.    Conclusions   47 Sc can be produced via the  48 Ti(γ,p) 47 Sc reaction and separated from natural Ti targets with a yield and radiochemical purity suitable for radiolabeling of peptides for in vitro studies. The data in this work supports the potential use of eLINACs for studies of photonuclear production of medical radionuclides and the future development of high-intensity eLINAC facilities capable of producing relevant quantities of carrier-free radionuclides currently inaccessible via routine production pathways or limited due to costly enriched targets.    Electronic supplementary material  The online version of this article (10.1186/s13550-019-0515-8) contains supplementary material, which is available to authorized users.

Photonuclear production, chemistry, and in vitro evaluation of the theranostic radionuclide 47Sc